|
SE506164C2
(sv)
*
|
1995-10-09 |
1997-11-17 |
Medscand Medical Ab |
Instrumentarium för behandling av urininkontinens hos kvinnor
|
|
US5972379A
(en)
*
|
1995-02-14 |
1999-10-26 |
Sequus Pharmaceuticals, Inc. |
Liposome composition and method for administering a quinolone
|
|
PT929293E
(pt)
*
|
1996-08-23 |
2004-03-31 |
Sequus Pharm Inc |
Lipossomas contendo um composto de cisplatina
|
|
FR2759293B1
(fr)
*
|
1997-02-11 |
1999-04-30 |
Ethypharm Lab Prod Ethiques |
Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
|
|
DE19724796A1
(de)
*
|
1997-06-06 |
1998-12-10 |
Max Delbrueck Centrum |
Mittel zur Antitumortherapie
|
|
DE69907243T2
(de)
|
1998-09-16 |
2004-02-19 |
Alza Corp., Mountain View |
In liposomen eingeschlossene topoisomerase inhibitoren
|
|
US20050084524A1
(en)
*
|
1998-09-30 |
2005-04-21 |
Alza Corporation |
Method for potentiating activity of a chemotherapeutic drug
|
|
US7226407B2
(en)
|
1999-06-09 |
2007-06-05 |
Ethicon, Inc. |
Surgical instrument and method for treating female urinary incontinence
|
|
US7083637B1
(en)
|
1999-06-09 |
2006-08-01 |
Tannhauser Robert J |
Method and apparatus for adjusting flexible areal polymer implants
|
|
US6932759B2
(en)
|
1999-06-09 |
2005-08-23 |
Gene W. Kammerer |
Surgical instrument and method for treating female urinary incontinence
|
|
US7121997B2
(en)
*
|
1999-06-09 |
2006-10-17 |
Ethicon, Inc. |
Surgical instrument and method for treating female urinary incontinence
|
|
US6511676B1
(en)
|
1999-11-05 |
2003-01-28 |
Teni Boulikas |
Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
|
|
CA2393595A1
(en)
*
|
1999-12-10 |
2001-06-14 |
Gigi Chiu |
Lipid carrier compositions with protected surface reactive functions
|
|
WO2001054666A1
(en)
*
|
2000-01-28 |
2001-08-02 |
Alza Corporation |
Liposomes containing an entrapped compound in supersaturated solution
|
|
US7131943B2
(en)
*
|
2000-03-09 |
2006-11-07 |
Ethicon, Inc. |
Surgical instrument and method for treating organ prolapse conditions
|
|
DE10019604C2
(de)
*
|
2000-04-20 |
2002-06-27 |
Ethicon Gmbh |
Implantat
|
|
JP2001336528A
(ja)
*
|
2000-05-25 |
2001-12-07 |
Ntn Corp |
磁気浮上装置
|
|
US7025063B2
(en)
*
|
2000-09-07 |
2006-04-11 |
Ams Research Corporation |
Coated sling material
|
|
DE60108405D1
(de)
*
|
2000-10-03 |
2005-02-17 |
Debiopharm Sa |
Plga/pla-typ mikrokugeln enthaltend eine wasserlösliche verbindung und herstellungsverfahren dafür
|
|
ES2260321T3
(es)
*
|
2000-12-07 |
2006-11-01 |
Universiteit Utrecht Holding B.V. |
Composicion para el tratamiento de transtornos inflamatorios.
|
|
US6652450B2
(en)
|
2001-01-23 |
2003-11-25 |
American Medical Systems, Inc. |
Implantable article and method for treating urinary incontinence using means for repositioning the implantable article
|
|
US6641525B2
(en)
|
2001-01-23 |
2003-11-04 |
Ams Research Corporation |
Sling assembly with secure and convenient attachment
|
|
US6612977B2
(en)
|
2001-01-23 |
2003-09-02 |
American Medical Systems Inc. |
Sling delivery system and method of use
|
|
DE10107165A1
(de)
*
|
2001-02-15 |
2002-08-29 |
Max Planck Gesellschaft |
Thermolabiles Liposom mit geregelter Freigabetemperatur
|
|
WO2002078672A2
(en)
*
|
2001-03-30 |
2002-10-10 |
Alza Corporation |
Liposomal tumor necrosis factor compositions and methods
|
|
CA2456746A1
(en)
*
|
2001-08-20 |
2003-02-27 |
Transave, Inc. |
Method for treating lung cancers
|
|
EP1424898A4
(en)
*
|
2001-08-20 |
2008-04-02 |
Transave Inc |
TREATMENT OF CANCER BY INHALATION OF STABLE FORMULATIONS CONTAINING PLATINUM
|
|
PL370867A1
(en)
*
|
2001-09-24 |
2005-05-30 |
Tosk, Inc. |
Reduced toxicity cisplatin formulations and methods for using the same
|
|
US7087065B2
(en)
*
|
2001-10-04 |
2006-08-08 |
Ethicon, Inc. |
Mesh for pelvic floor repair
|
|
ES2387886T3
(es)
*
|
2001-11-13 |
2012-10-03 |
Celator Pharmaceuticals, Inc. |
Composiciones que transportan lípidos con una mejor estabilidad sanguínea
|
|
US6476068B1
(en)
|
2001-12-06 |
2002-11-05 |
Pharmacia Italia, S.P.A. |
Platinum derivative pharmaceutical formulations
|
|
CN100592899C
(zh)
|
2002-03-01 |
2010-03-03 |
埃蒂康有限公司 |
用于治疗女性患者骨盆器官脱垂的方法和装置
|
|
JP2005530704A
(ja)
*
|
2002-03-05 |
2005-10-13 |
トランセイブ， インク． |
細胞内感染を予防及び治療するための吸入システム
|
|
US20110142922A1
(en)
*
|
2002-04-30 |
2011-06-16 |
Ferndale Ip, Inc. |
Stabilized composition and method for dermatological treatment
|
|
US20030215493A1
(en)
*
|
2002-04-30 |
2003-11-20 |
Patel Pravin M. |
Composition and method for dermatological treatment
|
|
US20090060992A1
(en)
*
|
2002-05-08 |
2009-03-05 |
University Of Central Florida Research Foundation, Inc., |
Preparation of magneto-vesicles with DOPE/DDAB layers
|
|
US20040022842A1
(en)
*
|
2002-06-03 |
2004-02-05 |
Mebiopharm Co., Ltd. |
Liposome preparations containing oxaliplatin
|
|
JP3415131B1
(ja)
|
2002-06-03 |
2003-06-09 |
メビオファーム株式会社 |
リポソーム製剤
|
|
US20050152962A1
(en)
*
|
2002-06-12 |
2005-07-14 |
Metselaar Josbert M. |
Composition for treatment of inflammatory disorders
|
|
AU2003302314A1
(en)
*
|
2002-08-02 |
2004-07-09 |
Transave, Inc. |
Platinum aggregates and process for producing the same
|
|
US9186322B2
(en)
|
2002-08-02 |
2015-11-17 |
Insmed Incorporated |
Platinum aggregates and process for producing the same
|
|
EP1393720A1
(en)
*
|
2002-08-27 |
2004-03-03 |
Universiteit Utrecht |
Vesicle-encapsulated corticosteroids for treatment of cancer
|
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
|
US7879351B2
(en)
*
|
2002-10-29 |
2011-02-01 |
Transave, Inc. |
High delivery rates for lipid based drug formulations, and methods of treatment thereof
|
|
EP3427742B1
(en)
*
|
2002-10-29 |
2020-08-12 |
Insmed Incorporated |
Liposomes comprising an aminoglycoside for the treatment of pulmonary infections
|
|
CA2506749A1
(en)
*
|
2002-11-26 |
2004-06-10 |
Gilead Sciences, Inc. |
Method of drug loading in liposomes by gradient
|
|
EP1587484A4
(en)
*
|
2002-12-19 |
2008-11-12 |
Alza Corp |
METHOD OF TREATING ANGIOGENIC TISSUE GROWTH
|
|
BR0317882A
(pt)
*
|
2002-12-31 |
2005-12-13 |
Bharat Serums & Vaccines Ltd |
Processo para fabricação de lipossomas de longa circulação não tratados com peg; lipossoma; composição de doxorrubicina lipossomal de longa duração não tratada com peg; e método
|
|
RU2005130172A
(ru)
*
|
2003-02-28 |
2006-03-20 |
Алза Корпорейшн (Us) Бus |
Липосомные композиции для уменьшения активизации комплемента, вызванной липосомами
|
|
US7968115B2
(en)
*
|
2004-03-05 |
2011-06-28 |
Board Of Regents, The University Of Texas System |
Liposomal curcumin for treatment of cancer
|
|
US20060198882A1
(en)
*
|
2003-03-21 |
2006-09-07 |
Yechezkel Barenholz |
Stable liposomes or micelles comprising a sphinolipid and a peg-lipopolymer
|
|
EP1628641A2
(en)
*
|
2003-05-19 |
2006-03-01 |
Baxter International Inc. |
Solid particles comprising an anticonvulsant or an immunosuppressive coated with one or more surface modifiers
|
|
WO2004103344A1
(en)
*
|
2003-05-20 |
2004-12-02 |
Aronex Pharmaceuticals, Inc. |
Combination chemotherapy comprising a liposomal platinum complex
|
|
JPWO2005018607A1
(ja)
*
|
2003-08-20 |
2007-11-01 |
味の素株式会社 |
溶解性を改善した医薬品製剤
|
|
CN100471493C
(zh)
*
|
2003-12-17 |
2009-03-25 |
梅比欧法姆股份有限公司 |
含有奥沙利铂的脂质体制剂
|
|
US8784881B2
(en)
*
|
2004-03-05 |
2014-07-22 |
Board Of Regents, The University Of Texas System |
Liposomal curcumin for treatment of diseases
|
|
US20080103213A1
(en)
*
|
2004-03-05 |
2008-05-01 |
Board Of Regents, The University Of Texas System |
Liposomal curcumin for treatment of neurofibromatosis
|
|
CA2559722A1
(en)
*
|
2004-03-18 |
2005-09-29 |
Transave, Inc. |
Administration of cisplatin by inhalation
|
|
US20070065522A1
(en)
*
|
2004-03-18 |
2007-03-22 |
Transave, Inc. |
Administration of high potency platinum compound formulations by inhalation
|
|
US8047982B2
(en)
*
|
2004-05-07 |
2011-11-01 |
Ethicon, Inc. |
Mesh tape with wing-like extensions for treating female urinary incontinence
|
|
WO2005112957A1
(en)
*
|
2004-05-21 |
2005-12-01 |
Transave, Inc. |
Treatment of lung diseases and pre-lung disease conditions
|
|
ES2485291T3
(es)
*
|
2004-07-28 |
2014-08-13 |
Ethicon, Inc. |
Un implante para su uso en el tratamiento de incontinencia urinaria de esfuerzo
|
|
JP2006056807A
(ja)
*
|
2004-08-18 |
2006-03-02 |
Konica Minolta Medical & Graphic Inc |
光線力学療法製剤
|
|
JP4715133B2
(ja)
*
|
2004-08-26 |
2011-07-06 |
コニカミノルタエムジー株式会社 |
抗腫瘍リポソーム製剤およびその製造方法
|
|
JP2006069929A
(ja)
*
|
2004-08-31 |
2006-03-16 |
Konica Minolta Medical & Graphic Inc |
真菌症治療製剤およびその製造方法
|
|
CA2579786A1
(en)
|
2004-09-09 |
2006-03-16 |
Yissum Research Development Company Of The Hebrew University Of Jerusale M |
Use of liposomal glucocorticoids for treating inflammatory states
|
|
US7527588B2
(en)
*
|
2004-09-15 |
2009-05-05 |
Ethicon, Inc. |
System and method for surgical implant placement
|
|
JP5735724B2
(ja)
*
|
2004-11-08 |
2015-06-17 |
インスメッド， インコーポレイテッド |
腹腔内投与される脂質ベースの白金化合物製剤を用いた、癌の治療方法
|
|
US7481314B2
(en)
*
|
2005-02-02 |
2009-01-27 |
Ethicon, Inc. |
Packaging assembly for surgical mesh implants
|
|
JP2006248978A
(ja)
*
|
2005-03-10 |
2006-09-21 |
Mebiopharm Co Ltd |
新規なリポソーム製剤
|
|
US20060283742A1
(en)
*
|
2005-06-16 |
2006-12-21 |
Canel Lightning Co. Ltd. |
Multi-lamp display packaging for lamps with collapsible lampshades
|
|
CN1913508B
(zh)
*
|
2005-08-08 |
2010-05-05 |
华为技术有限公司 |
基于正交频分复用的信号调制方法及其调制装置
|
|
US7855279B2
(en)
*
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
|
JP2009509535A
(ja)
*
|
2005-09-27 |
2009-03-12 |
アムニクス， インコーポレイテッド |
タンパク様薬剤およびその使用
|
|
US20090099031A1
(en)
*
|
2005-09-27 |
2009-04-16 |
Stemmer Willem P |
Genetic package and uses thereof
|
|
US7846445B2
(en)
*
|
2005-09-27 |
2010-12-07 |
Amunix Operating, Inc. |
Methods for production of unstructured recombinant polymers and uses thereof
|
|
US20070190182A1
(en)
*
|
2005-11-08 |
2007-08-16 |
Pilkiewicz Frank G |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
WO2007056236A2
(en)
*
|
2005-11-08 |
2007-05-18 |
Transave, Inc. |
Methods of treating cancer with lipid-based platinum compound formulations administered intravenously
|
|
US20070190180A1
(en)
*
|
2005-11-08 |
2007-08-16 |
Pilkiewicz Frank G |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intravenously
|
|
US9107824B2
(en)
|
2005-11-08 |
2015-08-18 |
Insmed Incorporated |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
US20070122350A1
(en)
*
|
2005-11-30 |
2007-05-31 |
Transave, Inc. |
Safe and effective methods of administering therapeutic agents
|
|
ES2798263T3
(es)
|
2005-12-08 |
2020-12-10 |
Insmed Inc |
Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares
|
|
AU2006332340B2
(en)
|
2005-12-30 |
2013-09-26 |
Zensun (Shanghai) Science & Technology, Co., Ltd. |
Extended release of neuregulin for improved cardiac function
|
|
JPWO2007089043A1
(ja)
*
|
2006-02-03 |
2009-06-25 |
武田薬品工業株式会社 |
リポソーム製剤
|
|
US20100034874A1
(en)
*
|
2006-12-08 |
2010-02-11 |
Katayama Chemical Industries Co., Ltd. |
Liposome encapsulating ammine-platinum complex at high concentration, and method for production of the liposome
|
|
WO2008079982A2
(en)
|
2006-12-21 |
2008-07-03 |
Centocor, Inc. |
Liposome composition for targeting egfr receptor
|
|
US8278415B2
(en)
|
2006-12-21 |
2012-10-02 |
Centocor, Inc. |
Dimeric high affinity EGFR constructs and uses thereof
|
|
WO2008079973A2
(en)
*
|
2006-12-21 |
2008-07-03 |
Centocor, Inc. |
Egfr binding peptides and uses thereof
|
|
US20100196455A1
(en)
*
|
2007-05-04 |
2010-08-05 |
Transave, Inc. |
Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
|
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
|
TW200916094A
(en)
*
|
2007-06-27 |
2009-04-16 |
Poniard Pharmaceuticals Inc |
Stabilized picoplatin dosage form
|
|
CN103298935A
(zh)
*
|
2007-08-15 |
2013-09-11 |
阿穆尼克斯公司 |
用于改善生物活性多肽性能的组合物和方法
|
|
ES2550759T3
(es)
|
2007-08-17 |
2015-11-12 |
Celator Pharmaceuticals, Inc. |
Formulaciones farmacológicas de platino mejoradas
|
|
CN101878229A
(zh)
|
2007-09-28 |
2010-11-03 |
巴塞尔大学医院 |
用于治疗癌症的免疫脂质体
|
|
US20090130017A1
(en)
*
|
2007-11-19 |
2009-05-21 |
Searete Llc |
Targeted short-lived drug delivery
|
|
TWI468188B
(zh)
*
|
2008-01-30 |
2015-01-11 |
Univ Tokushima |
Anti-cancer effect enhancers consisting of oxaliplatin liposomal preparations and anticancer agents comprising the formulation
|
|
KR101975843B1
(ko)
*
|
2008-05-23 |
2019-05-09 |
더 유니버시티 오브 브리티쉬 콜롬비아 |
리포좀 나노입자에 사용하기 위한 변형된 약물
|
|
US20100035853A1
(en)
*
|
2008-08-07 |
2010-02-11 |
Hyogo College Of Medicine |
Method for preventing or treating cisplatin-induced nephrotoxicity
|
|
US9322831B2
(en)
*
|
2008-09-23 |
2016-04-26 |
The Johns Hopkins University |
DDX3 as a biomarker for cancer and methods related thereto
|
|
US8449573B2
(en)
|
2008-12-05 |
2013-05-28 |
Boston Scientific Scimed, Inc. |
Insertion device and method for delivery of a mesh carrier
|
|
SI2393828T1
(sl)
|
2009-02-03 |
2017-01-31 |
Amunix Operating Inc. |
Podaljšani rekombinantni polipetidi in sestavki, ki jih obsegajo
|
|
US20110046060A1
(en)
|
2009-08-24 |
2011-02-24 |
Amunix Operating, Inc., |
Coagulation factor IX compositions and methods of making and using same
|
|
EP2228059A1
(en)
|
2009-03-12 |
2010-09-15 |
Universitätsspital Basel |
Chemotherapeutic composition for the treatment of cancer
|
|
US20120148661A1
(en)
*
|
2009-04-15 |
2012-06-14 |
Poniard Pharmaceuticals, Inc. |
High bioavailability oral picoplatin anti-cancer therapy
|
|
US8968334B2
(en)
|
2009-04-17 |
2015-03-03 |
Boston Scientific Scimed, Inc. |
Apparatus for delivering and anchoring implantable medical devices
|
|
AU2010258898B8
(en)
|
2009-06-08 |
2015-02-05 |
Amunix Operating Inc. |
Glucose-regulating polypeptides and methods of making and using same
|
|
JP5805634B2
(ja)
|
2009-06-08 |
2015-11-04 |
アムニクス オペレーティング インコーポレイテッド |
成長ホルモンポリペプチド並びにその作成及び使用方法
|
|
EP2440250A1
(en)
|
2009-06-11 |
2012-04-18 |
Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. |
Targeted liposomes comprising n-containing bisphosphonates and uses thereof
|
|
DK177529B1
(en)
*
|
2009-10-23 |
2013-09-08 |
Bio Bedst Aps |
Liposomes with improved storage stability
|
|
CA2778678A1
(en)
|
2009-10-30 |
2011-05-05 |
Cns Therapeutics, Inc. |
Improved neurturin molecules
|
|
US9301750B2
(en)
*
|
2009-11-03 |
2016-04-05 |
Boston Scientific Scimed, Inc. |
Device and method for delivery of mesh-based devices
|
|
EP2531175A2
(en)
|
2010-02-01 |
2012-12-12 |
Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. |
Liposomes comprising amphipathic drugs and method for their preparation
|
|
WO2012065044A2
(en)
|
2010-11-12 |
2012-05-18 |
Purdue Research Foundation |
Treating bladder tumor cells using fibronectin attachment protein as a target
|
|
EP2508176A1
(en)
|
2011-04-08 |
2012-10-10 |
Lipotarg Gmbh |
Novel combination treatment of cancer
|
|
ES2819059T3
(es)
|
2011-07-13 |
2021-04-14 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Liposomas que encapsulan conjuntamente un bifosfonato y un agente anfipático
|
|
WO2013114377A1
(en)
|
2012-02-02 |
2013-08-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd |
Stable liposomes for drug delivery
|
|
NZ628014A
(en)
|
2012-02-15 |
2016-09-30 |
Biogen Ma Inc |
Recombinant factor viii proteins
|
|
CN111548418A
(zh)
|
2012-02-15 |
2020-08-18 |
比奥贝拉蒂治疗公司 |
因子viii组合物及其制备和使用方法
|
|
ES2905368T3
(es)
|
2012-05-21 |
2022-04-08 |
Insmed Inc |
Sistemas para el tratamiento de infecciones pulmonares
|
|
LT3401402T
(lt)
|
2012-06-08 |
2020-12-28 |
Alkermes Pharma Ireland Limited |
Ligandai, modifikuoti cirkuliarinės permutacijos pagalba, kaip agonistai ir antagonistai
|
|
WO2014015016A1
(en)
|
2012-07-18 |
2014-01-23 |
Onyx Therapeutics, Inc. |
Liposomal compositions of epoxyketone-based proteasome inhibitors
|
|
MA37931A1
(fr)
*
|
2012-08-13 |
2016-07-29 |
Teni Boulikas |
Procédés améliorés permettant de traiter un cancer avec une toxicité rénale réduite
|
|
CA2883703C
(en)
|
2012-09-04 |
2021-10-19 |
Eleison Pharmaceuticals, Llc |
Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin
|
|
WO2014052634A1
(en)
*
|
2012-09-27 |
2014-04-03 |
The University Of North Carolina At Chapel Hill |
Lipid coated nanoparticles containing agents having low aqueous and lipid solubilities and methods thereof
|
|
WO2014085526A1
(en)
|
2012-11-29 |
2014-06-05 |
Insmed Incorporated |
Stabilized vancomycin formulations
|
|
WO2014100417A1
(en)
*
|
2012-12-19 |
2014-06-26 |
Blend Therapeutics, Inc. |
Compounds, compositions, and methods for the treatment of cancers
|
|
JP6077710B2
(ja)
*
|
2013-03-13 |
2017-02-08 |
マリンクロッド エルエルシー |
がん療法のためのリポソームシスプラチン組成物
|
|
BR112015022476A2
(pt)
*
|
2013-03-13 |
2017-07-18 |
Mallinckrodt Llc |
composições de oxaliplatina de lipossoma para terapia de câncer
|
|
US10548953B2
(en)
|
2013-08-14 |
2020-02-04 |
Bioverativ Therapeutics Inc. |
Factor VIII-XTEN fusions and uses thereof
|
|
US9987375B2
(en)
*
|
2013-09-23 |
2018-06-05 |
Amirhossein Sahebkar |
Method and composition for treatment of dyslipidemia and other diseases
|
|
KR102242875B1
(ko)
|
2014-03-25 |
2021-04-20 |
더 가번먼트 오브 더 유나이티드 스테이츠 오브 아메리카 에즈 리프리젠티드 바이 더 세크리터리 오브 더 아미 |
모노포스포릴 지질 a (mpla)-함유 리포솜 조성물 및 사포닌을 포함하는 무독성 아주반트 제제
|
|
PL3142643T3
(pl)
|
2014-05-15 |
2019-12-31 |
Insmed Incorporated |
Sposoby leczenia zakażeń płuc prątkami niegruźliczymi
|
|
AU2016233143B2
(en)
|
2015-03-17 |
2021-03-25 |
Alberto Gabizon |
Methods for the treatment of bladder cancer
|
|
AU2016301303B2
(en)
|
2015-08-03 |
2021-10-07 |
Bioverativ Therapeutics Inc. |
Factor IX fusion proteins and methods of making and using same
|
|
SG10202012205XA
(en)
|
2015-11-06 |
2021-01-28 |
Adjuvance Technologies Inc |
Triterpene saponin analogues
|
|
FR3051674B1
(fr)
*
|
2016-05-31 |
2019-11-08 |
Universite De Bourgogne |
Lipoproteines chargees en complexes de platine pour le traitement du cancer
|
|
EP3538546B1
(en)
|
2016-11-14 |
2025-01-08 |
Novartis AG |
Compositions, methods, and therapeutic uses related to fusogenic protein minion
|
|
WO2018102743A1
(en)
|
2016-12-02 |
2018-06-07 |
Bioverativ Therapeutics Inc. |
Methods of treating hemophilic arthropathy using chimeric clotting factors
|
|
IL292991A
(en)
|
2017-04-25 |
2022-07-01 |
Adjuvance Tech Inc |
Triterpene saponin analogs
|
|
AU2018350887A1
(en)
|
2017-10-16 |
2020-03-05 |
Adjuvance Technologies, Inc. |
Triterpene saponin analogues
|
|
US20190231690A1
(en)
*
|
2017-11-08 |
2019-08-01 |
L.E.A.F. Holdings Group Llc |
Platinum complexes and uses thereof
|
|
EP3773505A4
(en)
|
2018-03-30 |
2021-12-22 |
Insmed Incorporated |
PROCESS FOR THE CONTINUOUS MANUFACTURING OF LIPOSOMAL MEDICINAL PRODUCTS
|
|
AU2019262117C1
(en)
|
2018-05-02 |
2024-12-05 |
Insmed Incorporated |
Methods for the manufacture of liposomal drug formulations
|
|
JP7763589B2
(ja)
|
2018-05-18 |
2025-11-04 |
バイオベラティブ セラピューティクス インコーポレイテッド |
血友病ａを処置する方法
|
|
ES2998498T3
(en)
*
|
2020-03-10 |
2025-02-20 |
Univ Chung Yuan Christian |
Liposome composition and preparation method thereof
|
|
CA3182372A1
(en)
|
2020-06-25 |
2021-12-30 |
Amunix Pharmaceuticals, Inc. |
Her-2 targeted bispecific compositions and methods for making and using the same
|
|
CN117440972A
(zh)
|
2021-03-24 |
2024-01-23 |
奥克梅斯公司 |
Upar抗体和具有所述抗体的融合蛋白
|
|
CN114163481B
(zh)
*
|
2021-12-06 |
2023-06-23 |
郑州大学 |
一种含铂类药物纳米囊泡及其制备方法与应用
|
|
US20250177516A1
(en)
|
2022-03-14 |
2025-06-05 |
Pfizer Inc. |
Methods for producing an adjuvant
|
|
AU2023403045A1
(en)
|
2022-12-01 |
2025-06-12 |
Pfizer Inc. |
Pneumococcal conjugate vaccine formulations
|
|
CN116687860A
(zh)
*
|
2023-05-31 |
2023-09-05 |
广州鹏兴医药科技有限公司 |
顺铂靶向脂质体及其制备方法和应用
|
|
WO2025057058A1
(en)
|
2023-09-13 |
2025-03-20 |
Pfizer Inc. |
Methods for producing an adjuvant
|
|
WO2025191415A1
(en)
|
2024-03-11 |
2025-09-18 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated escherichia coli saccharides and uses thereof
|